Literature DB >> 7736791

Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma.

P J Renwick1, B R Reeves, P Dal Cin, C D Fletcher, H Kempski, R Sciot, B Kazmierczak, K Jani, H Sonobe, J C Knight.   

Abstract

Molecular analysis of a new series of synovial sarcomas confirms that t(X;18)(p11.2;q11.2) breakpoints occur at two distinct regions on Xp designated SS1 and SS2. Breakpoint position correlates with tumor phenotype. Monophasic tumors with no evidence of glandular components have breakpoints within the SS2 region in Xp11.21, and biphasic tumors with a focal poorly differentiated or extensive glandular structure have breakpoints within the SS1 region in Xp11.23.

Entities:  

Mesh:

Year:  1995        PMID: 7736791     DOI: 10.1159/000133992

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  5 in total

1.  Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma.

Authors:  J Shipley; J Crew; S Birdsall; S Gill; J Clark; C Fisher; A Kelsey; T Nojima; H Sonobe; C Cooper; B Gusterson
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

Review 2.  Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.

Authors:  J F Graadt van Roggen; J V Bovée; J Morreau; P C Hogendoorn
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

3.  Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma.

Authors:  E Tamborini; V Agus; A Mezzelani; C Riva; G Sozzi; A Azzarelli; M A Pierotti; S Pilotti
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

4.  Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Authors:  Cinzia Lanzi; Enrica Favini; Laura Dal Bo; Monica Tortoreto; Noemi Arrighetti; Nadia Zaffaroni; Giuliana Cassinelli
Journal:  J Exp Clin Cancer Res       Date:  2021-12-02

5.  Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.

Authors:  Myrella Vlenterie; Melissa H S Hillebrandt-Roeffen; Esther W M Schaars; Uta E Flucke; Emmy D G Fleuren; Anna C Navis; William P J Leenders; Yvonne M H Versleijen-Jonkers; Winette T A van der Graaf
Journal:  Ann Surg Oncol       Date:  2016-06-22       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.